2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular branch): Executive Summary
机构:[1]Department of Cardiology, Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing100853, China[2]Pulmonary Vessel and Thrombotic Disease, Sixth Medical Center, Chinese PLA General Hospital, Beijing100048, China[3]Department of Geriatrics, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China临床科室老年医学科/干部医疗科首都医科大学附属北京同仁医院首都医科大学附属同仁医院[4]Beijing Taikang Yanyuan Rehabilitation Hospital, Beijing 102299, China[5]Arrhythmia Center, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China[6]Geriatric Center, West China Hospital, Sichuan University, Chengdu 610044, China四川大学华西医院[7]Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom[8]Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark[9]Department of Geriatrics, Xijing Hospital, Air Force Military University, Xi’an 710032,China[10]Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China中山大学附属第二医院[11]Cardiology Center, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China首都医科大学附属安贞医院[12]Department of Arrhythmia, Sixth Medical Center, Chinese PLA General Hospital, Beijing100048, China[13]Department of Cardiology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200040, China[14]Department of Integrative Medicine, Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan 430073, China华中科技大学同济医学院附属同济医院[15]Department of Geriatrics, Changhai Hospital, Naval Medical University, Shanghai 200082, China[16]Department of Cardiology, Guizhou Provincial People's Hospital, Guiyang 550499, China[17]Jiangxi Provincial Cardiovascular Disease Hospital, Jiangxi Provincial People's Hospital, Nanchang 330006, China[18]Department of Cardiology, The Bethune Third Hospital of Jilin University, Jilin 130033, China吉林大学中日联谊医院[19]Henan Provincial Chest Hospital, Chest Hospital of Zhengzhou University, Zhengzhou 450008, China[20]Department of Cardiology, Northern Jiangsu People's Hospital, Affiliated Hospital to Yangzhou University, Clinical Medical School of Nanjing Medical University, Yangzhou 225001, China江苏省人民医院[21]Institute of cardiovascular Disease, Renmin Hospital of Wuhan University, Wuhan 430060, China[22]Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610044, China四川大学华西医院[23]Department of Cardiology, Department of Geriatrics, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029 , China江苏省人民医院
The consensus guidelines of the Geriatric Society of Chinese Medical Association (GSCMA) on the management of atrial fibrillation (AF) in the elderly was first published in 2011 and updated in 2016, with endorsement by Chinese Society of Geriatric Health Medicine (CSGHM). Since then, many important studies regarding the screening and treatment in the elderly population have been reported, necessitating this updated expert consensus guidelines. The writing committee members comprehensively reviewed updated evidence pertaining to elderly patients with AF, and formulated this 2024 update. The highlighted issues focused on the following: screening for AF, geriatric comprehensive assessment, use of the Atrial fibrillation Better Care (ABC) pathway for the elderly patients, and special clinical settings related to elderly patients with AF. New recommendations addressing smart technology facilitated AF screening, ABC pathway based management and optimal anticoagulation were developed, with a focus on the elderly.The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
基金:
The study was supported by Beijing Natural Science Foundation (L232117) ,National Natural
Science Foundation of China (82170309).
第一作者机构:[1]Department of Cardiology, Second Medical Center, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing100853, China
通讯作者:
推荐引用方式(GB/T 7714):
Wang Yutang,Guo Yutao,Qin Mingzhao,et al.2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular branch): Executive Summary[J].Thrombosis And Haemostasis.2024,doi:10.1055/a-2325-5923.
APA:
Wang Yutang,Guo Yutao,Qin Mingzhao,Fan Jin,Tang Ming...&Kejiang Cao.(2024).2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular branch): Executive Summary.Thrombosis And Haemostasis,,
MLA:
Wang Yutang,et al."2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular branch): Executive Summary".Thrombosis And Haemostasis .(2024)